pregnanolone has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benyounes, J; Bihel, F; Collongues, N; De Seze, J; Hallé, F; Klein, C; Leva, G; Mensah-Nyagan, AG; Patte-Mensah, C | 1 |
| Bues, B; Calignano, A; Carotenuto, A; Cerillo, I; Mangone, G; Orefice, G; Orefice, N; Rehm, R; Saccà, F | 1 |
2 other study(ies) available for pregnanolone and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.
Topics: Animals; Biomarkers; Brain; Cytokines; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Ligands; Mice; Mice, Inbred Strains; Multiple Sclerosis, Relapsing-Remitting; Myelin Basic Protein; Neurotransmitter Agents; Pregnanolone; Purines; Receptors, GABA; RNA, Messenger; Spinal Cord | 2017 |
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis.
Topics: Adult; Biomarkers; Brain; Dehydroepiandrosterone; Female; Humans; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pregnanolone; Pregnenolone; Recurrence | 2016 |